Refractory cytopenia with multilineage dysplasia (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Refractory cytopenia with multilineage dysplasia" in English language version.

refsWebsite

Global rank English rank

4^th place

2^nd place

11^th place

8^th place

doi.org

Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D (January 2009). "Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden". Biol. Blood Marrow Transplant. 15 (1): 30–8. doi:10.1016/j.bbmt.2008.10.012. PMID 19135940.
Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H (November 2008). "Clinical significance of regulatory T cells in patients with myelodysplastic syndrome". Eur. J. Haematol. 82 (3): 201–7. doi:10.1111/j.1600-0609.2008.01182.x. PMID 19018862. S2CID 3519094.^{[dead link]}

Rosati S, Mick R, Xu F, et al. (January 1996). "Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome". Leukemia. 10 (1): 20–6. PMID 8558932.
Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D (January 2009). "Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden". Biol. Blood Marrow Transplant. 15 (1): 30–8. doi:10.1016/j.bbmt.2008.10.012. PMID 19135940.
Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H (November 2008). "Clinical significance of regulatory T cells in patients with myelodysplastic syndrome". Eur. J. Haematol. 82 (3): 201–7. doi:10.1111/j.1600-0609.2008.01182.x. PMID 19018862. S2CID 3519094.^{[dead link]}

Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H (November 2008). "Clinical significance of regulatory T cells in patients with myelodysplastic syndrome". Eur. J. Haematol. 82 (3): 201–7. doi:10.1111/j.1600-0609.2008.01182.x. PMID 19018862. S2CID 3519094.^{[dead link]}